Send to

Choose Destination

See 1 citation found by title matching your search:

  • Showing results for T[Title] AND Cell-Signaling[Title] AND Network[Title] AND Analysis[Title] AND Reveals[Title] AND Distinct[Title] AND Differences[Title] AND CD28[Title] AND CD2[Title] AND Costimulation[Title] AND Responses[Title] AND Subsets[Title] AND MAPK[Title] AND Pathway[Title] AND Resting[Title] AND Activated[Title] AND Regulatory[Title] AND T[Title] AND Cells[Title]. Your search for T Cell-Signaling Network Analysis Reveals Distinct Differences between CD28 and CD2 Costimulation Responses in Various Subsets and in the MAPK Pathway between Resting and Activated Regulatory T Cells retrieved no results.
J Immunol. 2011 Nov 15;187(10):5233-45. doi: 10.4049/jimmunol.1101804. Epub 2011 Oct 19.

T cell-signaling network analysis reveals distinct differences between CD28 and CD2 costimulation responses in various subsets and in the MAPK pathway between resting and activated regulatory T cells.

Author information

Center for Molecular Medicine, Nordic European Molecular Biology Laboratory Partnership, University of Oslo, N-0318 Oslo, Norway.


To uncover signaling system differences between T cell stimuli and T cell subsets, phosphorylation status of 18 signaling proteins at six different time points following TCR triggering and CD28/CD2 costimulation was examined in human T cell subsets by phospho-epitope-specific flow cytometry of fluorescent cell barcoded samples, thereby providing a high-resolution signaling map. Compared with effector/memory T cells, naive T cells displayed stronger activation of proximal signaling molecules after TCR triggering alone. Conversely, distal phosphorylation events, like pErk and pS6-ribosomal protein, were stronger in effector/memory subsets. CD28 costimulation specifically induced signaling necessary for proper NF-κB activation, whereas CD2 signaled more strongly to S6-ribosomal protein. Analysis of resting regulatory T cells (rTregs; CD4(+)CD45RA(+)FOXP3(+)) and activated regulatory T cells (actTregs; CD4(+)CD45RA(-)FOXP3(++)) revealed that, although rTregs had low basal, but inducible, Erk activity, actTregs displayed high basal Erk phosphorylation and little or no Akt activation. Interestingly, the use of Mek inhibitors to block Erk activation inhibited activation-dependent FOXP3 upregulation in rTregs, their transition to actTregs, and the resulting increase in suppressive capacity. In summary, our systems approach unraveled distinct differences in signaling elicited by CD28 and CD2 costimulation and between rTregs and actTregs. Blocking rTreg transition to highly suppressive actTregs by Mek inhibitors might have future therapeutic applications.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center